Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: A case-control study

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Zhang, Donghong ^a   Zhang, Qingying ^a   Zhou, Li ^b   Huo, Leijun ^a   Zhang, Yi ^c   Shen, Zhongying ^a   Zhu, Yi ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b CANCER HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CHINA; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PREVALENCE; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; AGED; CANCER STAGING; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; ESOPHAGUS TUMOR; GENETICS; ISOLATION AND PURIFICATION; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY;

ONCOPROTEIN; VIRUS DNA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 78649334484     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-650     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Su M, Liu M, Tian DP, Li XY, Zhang GH, Yang HL, Fan X, Huang HH, Gao YX. Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely high-risk area in China. Eur J Epidemiol 2007, 22(1):43-48. 10.1007/s10654-006-9086-x, 17195051.
3. Ke L, Yu P, Zhang ZX. Novel epidemiologic evidence for the association between fermented fish sauce and esophageal cancer in South China. Int J Cancer 2002, 99(3):424-426. 10.1002/ijc.10293, 11992412.
4. Ke L, Yu P, Zhang ZX, Huang SS, Huang G, Ma XH. Congou tea drinking and oesophageal cancer in South China. Br J Cancer 2002, 86(3):346-347. 10.1038/sj.bjc.6600054, 2375216, 11875696.
5. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002, 55(10):721-728. 10.1136/jcp.55.10.721, 1769774, 12354793.
6. Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, Zeng Y. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002, 68(3):412-416. 10.1002/jmv.10219, 12226830.
7. Shen ZY, Cen S, Xu LY, Cai WJ, Chen MH, Shen J, Zeng Y. E6/E7 genes of human papilloma virus type 18 induced immortalization of human fetal esophageal epithelium. Oncol Rep 2003, 10(5):1431-1436.
8. Bao YP, Li N, Smith JS, Qiao YL. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis. Int J Std Aids 2008, 19(2):106-111. 10.1258/ijsa.2007.007113, 18334063.
9. Tabora N, Ferrera A, Bakkers JM, Massuger LF, Melchers WJ. High HPV 16 viral load is associated with increased cervical dysplasia in Honduran women. Am J Trop Med Hyg 2008, 78(5):843-846.
10. Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Cancer 2007, 121(10):2198-2204. 10.1002/ijc.22959, 17657742.
11. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 1995, 92(5):1654-1658. 10.1073/pnas.92.5.1654, 42578, 7878034.
12. Liu SS, Tsang PC, Chan KY, Cheung AN, Chan KK, Leung RC, Ngan HY. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas. Tumour Biol 2008, 29(2):105-113. 10.1159/000135690, 18515988.
13. Si HX, Tsao SW, Poon CS, Wong YC, Cheung AL. Physical status of HPV-16 in esophageal squamous cell carcinoma. J Clin Virol 2005, 32(1):19-23. 10.1016/j.jcv.2004.04.004, 15572001.
14. Ruutu MP, Kulmala SM, Peitsaro P, Syrjanen SM. The performance of the HPV16 real-time PCR integration assay. Clin Biochem 2008, 41(6):423-428. 10.1016/j.clinbiochem.2007.12.014, 18206116.
15. Szostek S, Zawilinska B, Kopec J, Kosz-Vnenchak M. Herpesviruses as possible cofactors in HPV-16-related oncogenesis. Acta Biochim Pol 2009, 56(2):337-342.
16. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006, 44(5):1755-1762. 10.1128/JCM.44.5.1755-1762.2006, 1479176, 16672403.
17. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Modern Pathology 2007, 20(2):256-266. 10.1038/modpathol.3800737, 17192787.
18. Cui L, Xu LY, Shen ZY, Tao Q, Gao SY, Lv Z, Du ZP, Fang WK, Li EM. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clin Cancer Res 2008, 14(23):7674-7681. 10.1158/1078-0432.CCR-08-0420, 19047093.
19. Qi ZL, Huo X, Xu XJ, Zhang B, Du MG, Yang HW, Zheng LK, Li J, Shen ZY. Relationship between HPV16/18 E6 and 53, 21WAF1, MDM2, Ki67 and cyclin D1 expression in esophageal squamous cell carcinoma: comparative study by using tissue microarray technology. Exp Oncol 2006, 28(3):235-240.
20. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007, 121(3):621-632. 10.1002/ijc.22527, 17405118.
21. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, Lu C, Wang Z, Shi X, Zhang Q, Zhang D, Shen Z, Li F, Harris CC, Cai H, Ke Y. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. Bmc Cancer 2010, 10(1):19. 10.1186/1471-2407-10-19, 2826296, 20078887.
22. Dreilich M, Bergqvist M, Moberg M, Brattstrom D, Gustavsson I, Bergstrom S, Wanders A, Hesselius P, Wagenius G, Gyllensten U. High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. Bmc Cancer 2006, 6:94. 10.1186/1471-2407-6-94, 1475606, 16620378.
23. Si HX, Tsao SW, Poon CS, Wang LD, Wong YC, Cheung AL. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 2003, 103(4):496-500. 10.1002/ijc.10865, 12478665.
24. Beby-Defaux A, Bourgoin A, Ragot S, Battandier D, Lemasson JM, Renaud O, Bouguermouh S, Vienne MML, Agius G. Human papillomavirus infection of the cervix uteri in women attending a Health Examination Center of the French social security. J Med Virol 2004, 73(2):262-268. 10.1002/jmv.20085, 15122802.
25. Hildesheim A, Wang SS. H ost and viral genetics and risk of cervical cancer: a review. Virus Res 2002, 89(2):229-240. 10.1016/S0168-1702(02)00191-0, 12445662.
26. Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C, Akiba S. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007, 96(10):1554-1559. 10.1038/sj.bjc.6603765, 2359949, 17453003.
27. Koskinen WJ, Chen RW, Leivo I, Mäkitie A, Bäck L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, Aaltonen LM. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003, 107(3):401-406. 10.1002/ijc.11381, 14506740.
28. Zehbe I, Rylander E, Edlund K, Wadell G, Wilander E. Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques. Virchows Arch 1996, 428(3):151-157. 10.1007/BF00200657, 8688969.
29. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005, 11(16):5694-5699. 10.1158/1078-0432.CCR-05-0587, 16115905.
30. Bodaghi S, Yamanegi K, Xiao SY, Da CM, Palefsky JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005, 11(8):2862-2867. 10.1158/1078-0432.CCR-04-1680, 1479314, 15837733.
31. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, Rush BB, Gravitt PE, Schussler JE, Schiffman M. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002, 360(9328):228-229. 10.1016/S0140-6736(02)09463-1, 12133661.
32. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Durst M, Schneider A, von Knebel DM. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res 2008, 68(1):307-313. 10.1158/0008-5472.CAN-07-2754, 18172324.
33. Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA, Coleman N. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 2002, 62(23):6959-6965.
34. Ragin CC, Reshmi SC, Gollin SM. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 2004, 110(5):701-709. 10.1002/ijc.20193, 15146560.
35. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel DM. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003, 22(25):3977-3984. 10.1038/sj.onc.1206629, 12813471.